Genome & Company Market Cap

Genome & Company has a market cap or net worth of 90.30 billion as of February 21, 2025. Its market cap has decreased by -43.16% in one year.

Market Cap

90.30B

Enterprise Value

94.17B

Revenue

24.09B

Ranking

n/a

PE Ratio

n/a

Stock Price

2,905.00

Market Cap Chart

Since December 26, 2018, Genome & Company's market cap has increased from 71.88B to 90.30B, an increase of 25.63%. That is a compound annual growth rate of 3.77%.

Market Cap History

Date	Market Cap	% Change
Feb 21, 2025	90.30B	5.98%
Dec 30, 2024	85.21B	-51.64%
Dec 28, 2023	176.21B	-28.34%
Dec 29, 2022	245.90B	-47.55%
Dec 30, 2021	468.83B	-55.28%
Dec 30, 2020	1,048.46B	224.28%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Electronics	384.51T
SK hynix	144.35T
LG Energy Solution	88.57T
Samsung Biologics	82.35T
Hyundai Motor Company	45.50T
Celltrion	37.80T
Kia Corporation	36.86T
NAVER	34.26T

Market Cap Rankings